Breaking News
Get 45% Off 0
🚀 Get a powerful boost to your portfolio: June's freshest AI-picked stocks
Unlock Stocks
Close

MRNA 80.82SPLOPENS (DE000SD09YZ9)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MRNA 80.82SPLOPENS historical data, for real-time data please try another search
0.720 0.000    0.00%
16/10 - Closed. Currency in
Type:  Certificate
Market:  France
Issuer: 
ISIN:  DE000SD09YZ9 
Underlying:  Moderna
Asset Class:  Equity
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.585 - 1.130
MRNA 80.82SPLOPENS 0.720 0.000 0.00%

DE000SD09YZ9 News

 
The latest news and headlines about the MRNA 80.82SPLOPENS certificate.
Moderna's H5 avian flu vaccine shows promise in early trial
Moderna's H5 avian flu vaccine shows promise in early trial By Investing.com - May 29, 2025

CAMBRIDGE, MA - Moderna, Inc. (NASDAQ:MRNA), the $10 billion biotech company whose shares have declined over 37% year-to-date, has disclosed positive interim data from its Phase 1/2 study assessing...

Moderna to Present at Upcoming Conferences in June 2025
Moderna to Present at Upcoming Conferences in June 2025 By Investing.com - May 27, 2025

CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: Jefferies Global Health Care...

Moderna seeks FDA nod for updated COVID-19 vaccine formula
Moderna seeks FDA nod for updated COVID-19 vaccine formula By Investing.com - May 23, 2025

CAMBRIDGE, MA - Moderna, Inc. (NASDAQ:MRNA), currently valued at $10.2 billion, has announced its submission of an updated COVID-19 vaccine formula, Spikevax 2025-2026, for review by the U.S. Food and...

Moderna files FDA application for Spikevax formula
Moderna files FDA application for Spikevax formula By Investing.com - May 23, 2025

Moderna , Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the...

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DE000SD09YZ9 Comments

Write your thoughts about MRNA 80.82SPLOPENS
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email